Discover 1,239 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,239
Active & Responsive
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Nashville TN, Zion IL, Jacksonville FL, Fairfax VA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07277413
Phase 1, Recruiting
Active & Responsive
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
for
Breast Cancer, Breast Neoplasm, Breast Cancer Stage IV
Location: Nashville TN, Sarasota FL, Beverly Hills CA
Location: Denver CO, Nashville TN, Chicago IL, Durham NC,
Sponsor: Pheast Therapeutics
Sex: All
Age: 18+
Code: NCT06840886
Phase 1, Recruiting
Active & Responsive
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
for
Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC),
Location: Nashville TN
Sponsor: Janux Therapeutics
Sex: Male
Age: 18+
Code: NCT07813637
Phase 1, Recruiting
Active & Responsive
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
for
Colorectal Cancer
Location: Nashville TN, Indianapolis IN, St Louis MO,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659795
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Nashville TN, Grand Rapids MI, Toronto, Houston TX,
Sponsor: Ipsen
Sex: All
Age: 18+
Code: NCT07213830
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
for
Uveal Melanoma
Location: Nashville TN, Toronto, Philadelphia PA, Scottsdale AZ
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07804186
Phase 3, Recruiting
Active & Responsive
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer